Overview
- In posts on X and LinkedIn, he said there has been no commercial announcement and no official benchmarking data.
- The device is described as an experimental brain blood-flow monitor linked to his Gravity Ageing Hypothesis and has been self-tested for about a year.
- A physician from AIIMS Delhi and other commentators criticized the gadget, with some calling it a "fancy Billionaires' toy" and a "waste of money."
- Goyal asked detractors to wait for evidence, saying the science will be published only if Temple is taken to market.
- He reiterated that any public preview is months away, following viral speculation after the device appeared during a podcast.